Kirby Institute at UNSW, Friday July 2nd, 2021
New research from the Kirby Institute at UNSW Sydney shows that HIV transmissions are at historically low rates among almost 10,000 high-risk gay and bisexual men on pre-exposure prophylaxis (PrEP), the HIV prevention medication.
Low HIV rates persisted after PrEP moved from being available cost-free as part of a NSW clinical trial, to being available at a subsidised cost through the Australian Pharmaceutical Benefits Scheme (PBS) in 2018.
The research, funded by NSW Health and published today in The Lancet HIV, is the culmination of a three-year study called EPIC-NSW, which was the first study globally to measure the impact of PrEP on reducing HIV in a large population.
- Read more of press release here
- Access abstract of journal paper here (see your librarian for full text access)
- Read media article from The Guardian here